CFO Richard Eisenstadt resigns effective Dec 30, 2021; successor search underway

AYTU BIOPHARMA, INC

Richard I. Eisenstadt resigns as CFO effective Dec 30, 2021 to pursue opportunity at another development-stage pharma.
Resignation not due to any disagreements with Company's operations, policies, practices, or auditors.
Company has initiated a search to identify and recruit a new CFO; CEO Josh Disbrow signing the filing.
No interim CFO named; current CFO to depart at month-end.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Richard I. Eisenstadt

Chief Financial Officer

AYTU · AYTU BIOPHARMA, INC

Effective: 2021-12-30
Filed: December 13, 2021, 6:59 PM ET

On December 8, 2021, Richard I. Eisenstadt resigned as Chief Financial Officer of Aytu BioPharma, Inc. (the “Company”), effective December 30, 2021, to pursue another opportunity at a development-stage pharmaceutical company.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Richard I. Eisenstadt resigned as Chief Financial Officer at AYTU BIOPHARMA, INC.

Action: resigned
Role: Chief Financial Officer

Exact text from the filing

On December 8, 2021, Richard I. Eisenstadt resigned as Chief Financial Officer of Aytu BioPharma, Inc. (the “Company”), effective December 30, 2021, to pursue another opportunity at a development-stage pharmaceutical company.

View on SEC.gov

AYTU BIOPHARMA, INC filing history →

Source: SEC EDGAR

accession 0001558370-21-016698

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.